<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom"><title>Health task force appointees allowed to keep drug stocks under ethics waivers (INV-077): updates, Public Trust Tracker</title><id>https://publictrusttracker.org/case/inv-077-health-task-force-appointees-allowed-to-keep-drug-stocks/</id><link href="https://publictrusttracker.org/case/inv-077-health-task-force-appointees-allowed-to-keep-drug-stocks/"/><link rel="self" href="https://publictrusttracker.org/case/inv-077-health-task-force-appointees-allowed-to-keep-drug-stocks/feed.xml"/><updated>2026-11-05T00:00:00Z</updated><author><name>Public Trust Tracker</name></author><entry><title>INV-077, 5 Nov 2026: The New York Times reports that four of them, Drs. Patrick Hunter, Ronald Karlsberg,…</title><id>https://publictrusttracker.org/case/inv-077-health-task-force-appointees-allowed-to-keep-drug-stocks/#59e3b942e8</id><link href="https://publictrusttracker.org/case/inv-077-health-task-force-appointees-allowed-to-keep-drug-stocks/"/><updated>2026-11-05T00:00:00Z</updated><summary>The New York Times reports that four of them, Drs. Patrick Hunter, Ronald Karlsberg, Venkatesh Murthy and Dennis Wulfeck, received AHRQ waivers to serve while owning drug-company stocks, including Eli Lilly, Johnson &amp; Johnson, Merck, Pfizer and Novo Nordisk; according to the waivers, the companies make up no more than 15 to 45 percent of each member&#x27;s portfolio.</summary></entry></feed>
